An early-biomarker algorithm predicts lethal graft-versus-host disease and survival

BACKGROUND. No laboratory test can predict the risk of nonrelapse mortality (NRM) or severe graft-versus-host disease (GVHD) after hematopoietic cellular transplantation (HCT) prior to the onset of GVHD symptoms. METHODS. Patient blood samples on day 7 after HCT were obtained from a multicenter set...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JCI Insight
Main Authors: Hartwell, Matthew J., Özbek, Umut, Holler, Ernst, Renteria, Anne S., Major-Monfried, Hannah, Reddy, Pavan, Aziz, Mina, Hogan, William J., Ayuk, Francis, Efebera, Yvonne A., Hexner, Elizabeth O., Bunworasate, Udomsak, Qayed, Muna, Ordemann, Rainer, Wölfl, Matthias, Mielke, Stephan, Pawarode, Attaphol, Chen, Yi-Bin, Devine, Steven, Harris, Andrew C., Jagasia, Madan, Kitko, Carrie L., Litzow, Mark R., Kröger, Nicolaus, Locatelli, Franco, Morales, George, Nakamura, Ryotaro, Reshef, Ran, Rösler, Wolf, Weber, Daniela, Wudhikarn, Kitsada, Yanik, Gregory A., Levine, John E., Ferrara, James L.M.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Clinical Investigation 2017
Assuntos:
Clinical Medicine
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5291735/
https://ncbi.nlm.nih.gov/pubmed/28194439
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.89798
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados